Financial & Tax Architects LLC lessened its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 93.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,754 shares of the company's stock after selling 56,882 shares during the period. Financial & Tax Architects LLC's holdings in Colgate-Palmolive were worth $341,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. D Orazio & Associates Inc. grew its holdings in Colgate-Palmolive by 3.9% during the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company's stock worth $297,000 after acquiring an additional 108 shares during the period. Fiducient Advisors LLC grew its position in shares of Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company's stock worth $232,000 after buying an additional 110 shares during the period. Sequoia Financial Advisors LLC increased its stake in shares of Colgate-Palmolive by 0.6% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company's stock valued at $2,117,000 after acquiring an additional 113 shares in the last quarter. Great Waters Wealth Management boosted its stake in Colgate-Palmolive by 1.5% during the third quarter. Great Waters Wealth Management now owns 7,669 shares of the company's stock worth $796,000 after acquiring an additional 117 shares in the last quarter. Finally, Waldron Private Wealth LLC grew its holdings in Colgate-Palmolive by 2.1% in the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company's stock worth $585,000 after purchasing an additional 118 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on CL shares. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research report on Tuesday, January 7th. StockNews.com cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Piper Sandler lowered their target price on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research report on Monday, January 6th. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating for the company in a research report on Friday. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating on the stock in a report on Thursday. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $101.11.
Check Out Our Latest Stock Report on Colgate-Palmolive
Colgate-Palmolive Price Performance
NYSE CL traded up $0.23 during trading on Friday, reaching $88.79. The company's stock had a trading volume of 5,149,874 shares, compared to its average volume of 3,679,883. The stock has a market capitalization of $72.55 billion, a PE ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a fifty day moving average of $92.20 and a 200 day moving average of $97.75. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30.
Colgate-Palmolive Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.25%. Colgate-Palmolive's payout ratio is presently 57.31%.
Insider Activity at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.34% of the stock is owned by insiders.
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.